Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036594 · ClinicalTrials.gov registry record · Phase 2
Ketoconazole and Dexamethasone in Prostate Cancer
A Phase 2 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT01036594 is a Phase 2 study that has completed, run by University of California, San Francisco. The registered enrollment target is 32 participants.
The verdict
NCT01036594, a Phase 2 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is an open label, phase II, single center trial of ketoconazole/dexamethasone to determine if the administration of ketoconazole/dexamethasone, after disease progression with ketoconazole/hydrocortisone slows or reverses disease progression in men with progressive prostate cancer.
Interventions
- DRUG Dexamethasone
- DRUG Hydrocortisone
- DRUG Ketoconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2009-12-11 |
| Est. Completion | 2014-10-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036594
The ClinicalTrials.gov registry entry for NCT01036594 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Dexamethasone is the first listed.
NCT01036594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01036594 about?
NCT01036594 is a clinical study titled "Ketoconazole and Dexamethasone in Prostate Cancer". This is an open label, phase II, single center trial of ketoconazole/dexamethasone to determine if the administration of ketoconazole/dexamethasone, after disease progression with ketoconazole/hydrocortisone slows or reverses disease progression in men with progressive prostate cancer.
What is the current status of trial NCT01036594?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 2009-12-11. Estimated completion is 2014-10-09.
What interventions are being tested in trial NCT01036594?
The interventions under investigation include: Dexamethasone (DRUG), Hydrocortisone (DRUG), Ketoconazole (DRUG).
Who is sponsoring clinical trial NCT01036594?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.